Inside informationEnglish
Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 22/04/2026, 07:05
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 117134_20260422